Atrial Fibrillation Clinical Trials in Wenzhou, Zhejiang
3 recruitingWenzhou, Zhejiang, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Not Applicable
Left Roof Linear, Mitral Isthmus Linear and Left Anterior Septal Linear Ablation for Non-paroxysmal AF: PROMISED Trial.
Atrial FibrillationAtrial Fibrillation, Persistent
Second Affiliated Hospital of Wenzhou Medical University166 enrolled1 locationNCT06249347
Recruiting
Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events
Non Valvular Atrial FibrillationEmbolic Stroke
Lifetech Scientific (Shenzhen) Co., Ltd.579 enrolled5 locationsNCT04559243